Humana, CVS Health In the Running to Acquire Cano Health - Reports
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St slips as steep oil prices stoke inflation concerns ahead of CPI
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- Harry and Meghan surprised by King Charles' letter on their status
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Wall St slips as steep oil prices stoke inflation concerns ahead of CPI
- Qualcomm to issue warrant to Amazon for up to 25M shares
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
CVS Health reports progress against goal to reduce suicide attempts among Aetna members 20% by 2025
September 22, 2022 8:00 AM EDTSuicide prevention strategy propelled a significant reduction in suicide attempts among adult members
Goal inspired by American Foundation for Suicide Prevention's Project 2025 initiative
WOONSOCKET, R.I., Sept. 22, 2022 /PRNewswire/ -- Today, CVS Health® (NYSE: CVS) announced its milestone progress against the goal set last year of reducing Aetna member suicide attempts 20% by 2025.
CVS Health announces quarterly dividend
September 21, 2022 6:16 PM EDTWOONSOCKET, R.I., Sept. 21, 2022 /PRNewswire/ -- CVS Health (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of fifty-five cents ($0.55) per share on the Common Stock of the Corporation. The dividend is payable on November 1,... More
